Champix Dubbed As A Suitable Quit Smoking Treatment By National Institute For Health And Clinical Excellence In UK
Date: 31st May 2007
According to a latest revelation, the National Institute for Health and Clinical Excellence (NICE) in UK has suggested the anti-smoking drug champix, a product of Pfizer Incl., as an effective quit smoking treatment and has further recommended the drug treatment to be added to the National Health Service (NHS).
In the US , champix is known as chantix and has been approved by FDA (Food and Drugs Administration) on May 2006 as an effective smoking cessation treatment for adults. However, in the UK , champix was authorized for sale only on September 2006.
By considering champix more effective than nicotine replacement therapy and bupropion with regard to the action of the drug against smoking addiction, NICE concludes that champix can be used as a cost-effective solution for smoking addiction by the National Health Service.